stavros
Uploaded by
42 SLIDES
640 VUES
420LIKES

HIV/HCV Co-Infection Case

DESCRIPTION

HIV/HCV Co-Infection Case. Disclosures. Treatment History. Laboratory Values. SVR in HIV/HCV Pts According to IL28B. Factors Associated with SVR in HIV HCV Treated Pts. IL-28B and DAA. Laboratory Values. Any other issues that need to be addressed before treatment?.

1 / 42

Télécharger la présentation

HIV/HCV Co-Infection Case

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV/HCV Co-Infection Case

  2. Disclosures

  3. Treatment History

  4. Laboratory Values

  5. SVR in HIV/HCV Pts According to IL28B

  6. Factors Associated with SVR in HIV HCV Treated Pts.

  7. IL-28B and DAA

  8. Laboratory Values

  9. Any other issues that need to be addressed before treatment?

  10. Insulin Resistance Influences Response to Treatment with PegIFN/RBV in HIV/HCV Co-Infected Patients

  11. Insulin Resistance Influences Response to Re-Treatment with PegIFN/RBV in HIV/HCV Co-Infected Patients

  12. Multi-variable AnalysisOutcome = SVR

  13. Does Vitamin D Play a Role?

  14. Does Vitamin D Play a Role?

  15. June 2011

  16. What do you recommend to this HIV-HCV cirrhotic patient?

  17. Is the patient’s HIV regimen compatible with DAA?

  18. DAA and co-infected patients

  19. Telaprevir and co-infected: Study 110

  20. Telaprevir and co-infected: Study 110

  21. Boceprevir and co-infected

  22. Boceprevir and co-infected

  23. Pharmacokinetic interactions

  24. Summer 2011

  25. HCV viral load

  26. CBC

  27. Cytopenias and DAA

  28. What would you recommend?

  29. Growth factors and hepatitis C treatment

  30. Growth factors and hepatitis C treatment

  31. EPO

  32. G-CSF

  33. Thrombopoietic agents

  34. CBC

  35. January 2012

  36. RGT

  37. Telaprevir response guided therapy (RGT)

  38. February 13th 2012

More Related